Literature DB >> 2998873

Action of cobra venom cardiotoxin on chick embryonal fibroblasts transformed with a temperature-sensitive mutant of Rous sarcoma virus.

N Kaneda, M Hamaguchi, K Kojima, H Kaneshima, K Hayashi.   

Abstract

The cytolytic action of cardiotoxin analogue III from the venom of the Formosan cobra on chick embryonal fibroblasts transformed with a temperature-sensitive mutant of Rous sarcoma virus was investigated. The 50% effective dose of the toxin for the cells cultured at a non-permissive temperature (41 degrees C) or for noninfected normal cells was about 8 micrograms/ml whereas the value was 2 micrograms/ml for the cells cultured at a permissive temperature (36 degrees C). This indicates that the transformed cells became more susceptible to the cytolytic action of the toxin than the non-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998873     DOI: 10.1016/0014-5793(85)80132-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  In vitro comparison of cytotoxic effects of crotoxin against three human tumors and a normal human epidermal keratinocyte cell line.

Authors:  C J Rudd; L J Viskatis; J C Vidal; M A Etcheverry
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

2.  VRCTC-310--a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity.

Authors:  R A Newman; J C Vidal; L J Viskatis; J Johnson; M A Etcheverry
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

Review 3.  Antitumoral activity of snake venom proteins: new trends in cancer therapy.

Authors:  Leonardo A Calderon; Juliana C Sobrinho; Kayena D Zaqueo; Andrea A de Moura; Amy N Grabner; Maurício V Mazzi; Silvana Marcussi; Auro Nomizo; Carla F C Fernandes; Juliana P Zuliani; Bruna M A Carvalho; Saulo L da Silva; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.